Cat.#: ACPP-1334
| Despition | DRP1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1125 | Recombinant Human ERAB Protein (S Tag) (AC1125) | 50 µg | inquiry |
| ACPP-1047 | Recombinant Human Myelin Basic Protein Protein (Fc Tag) (AC1047) | 50 µg | inquiry |
| ACPP-1354 | PAX2 Blocking Peptide (AC1354) | 250 µg | inquiry |
| ACPP-1038 | Recombinant Human VCAM1 Protein (6×His Tag) (AC1038) | 50 µg | inquiry |
| ACPP-1192 | Human WNT3A Protein (AC1192) | 5 µg | inquiry |
| ACPP-1194 | Calcium Sensing Receptor Blocking Peptide (AC1194) | 250 µg | inquiry |
| ACPP-1311 | Human LIF Protein (AC1311) | 3 x 2 µg | inquiry |
| ACPP-1056 | Recombinant Human CX3CR1 Protein (Fc Tag) (AC1056) | 50 µg | inquiry |
| ACPP-1213 | CACNB2 Blocking Peptide (AC1213) | 250 µg | inquiry |
| ACPP-1595 | Mouse DLL4 Protein (AC1595) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.